---

​Biotech Hanse, the Swedish-German Biotech Association, aims at connecting the biotech and life-science sectors of Sweden and Germany, respectively the Nordic and German language regions in general. The main focus areas of this non-profit organization are bilateral events, collaborations, exchange of knowledge and networking opportunities. Biotech Hanse addresses companies in the life science and medtech field, venture capital, tech transfer offices and other providers of services in this field. Biotech Hanse allows for personal membership as well as membership for legal entities like companies and other organizations. Biotech Hanse, founded 2014, is based in Stockholm and is led by bilingual (Swedish/German) executives.

The Biotech Hanse Forum assembles key players and emerging companies from the Swedish and German (language region) Pharma and Biotech Industry and provides a unique opportunity to present to a selected audience. 
​​

​The 8th Biotech Hanse Forum took place on 9 June 2026 with 52 registered participants from 41 companies and organisations . We listened to 25 pitches and presentations during the day, with a lot of questions and discussion. We mingled and networked at the offices of Vinnova, Sweden's Innovation Agency, in central Stockholm, and later on at the restaurant Österlånggatan 17 in Gamla Stan, Stockholm's Old Town. Feedback from participants was positive through-out, and several reported budding business relationships. A list of participating companies and organisations as well as photographs can be found here.

Follow us on LinkedIn for additional information and announcements! 
www.linkedin.com/company/biotech-hanse/
​
Previous Keynote presentations have been held by companies and investors such as
Boehringer Ingelheim, Bayer Healthcare, AstraZeneca, High-Tech Gründerfonds, Novo Nordisk, Wellington Partners, and many more.